{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:22:43Z","timestamp":1793330563017,"version":"4.5.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>Anaplastic Large CellLymphomas (ALCLs) carry translocations in which the anaplastic lymphoma kinase (ALK) gene is juxtaposed to various genes, the most common of which is the NPM\/B23gene. ALK fusion proteins result in the constitutive activation of ALK tyrosine kinase, thereby enhancing proliferation and increasing cell survival. A direct role for NPM-ALK in cellular transformation has been shown in vitro with immortalized cell lines and in vivo using retroviral transfer experiments. Nonetheless, there is no direct evidence of its oncogenic potential in T lymphocytes, which represent the most common target of ALK chimeras. Here, we describe a new mouse model of lymphomagenesis in which human NPM-ALK transcription was targeted to T cells. NPM-ALK transgenic (Tg) mice were born with the expected mendelian distribution, normal lymphoid organs, and a normal number and proportion of helper and suppressor T cells. However, after a short period of latency, all NPM-ALK Tg mice developed malignant lymphoproliferative disorders (mean survival, 18 weeks). NPM-ALK Tg thymic lymphomas displayed a T-cell phenotype characteristic of immature thymocytes and frequently coexpressed surface CD30. A subset of the NPM-ALK Tg mice also developed clonal B-cell plasma cell neoplasms. These tumors arose in peripheral lymphoid organs (plasmacytomas) or within the bone marrow and often led to peripheral neuropathies and limb paralysis. Our NPM-ALK Tg mice are a suitable model to dissect the molecular mechanisms of ALK-mediated transformation and to investigate the efficacy of new therapeutic approaches for the treatment of human ALCL in vivo.<\/jats:p>","DOI":"10.1182\/blood-2002-05-1343","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T14:59:36Z","timestamp":1045061976000},"page":"1919-1927","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":219,"title":["NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors"],"prefix":"10.1182","volume":"101","author":[{"given":"Roberto","family":"Chiarle","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerald Z.","family":"Gong","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Guasparri","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pesci","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonjing","family":"Cai","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Simmons","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dhall","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Howes","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Piva","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York; Department of Pathology and Centro di Ricerca in Medicina Sperimentale (CERMS), University of Torino, Torino, Italy; Department of Pathology, University of Verona, Verona, Italy; Department of Pathology, University of Cornell, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111900465931200_B1","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.","volume":"96","author":"Stein","year":"2000","journal-title":"Blood."},{"key":"2019111900465931200_B2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.1989.tb06270.x","article-title":"A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (\u2018Ki-1 lymphoma\u2019).","volume":"71","author":"Rimokh","year":"1989","journal-title":"Br J Haematol."},{"key":"2019111900465931200_B3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V73.3.806.806","article-title":"A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis.","volume":"73","author":"Kaneko","year":"1989","journal-title":"Blood."},{"key":"2019111900465931200_B4","first-page":"866","article-title":"The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.","volume":"3","author":"Le Beau","year":"1989","journal-title":"Leukemia."},{"key":"2019111900465931200_B5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.","volume":"263","author":"Morris","year":"1994","journal-title":"Science."},{"key":"2019111900465931200_B6","first-page":"33","article-title":"Expression and subcellular locations of two forms of nucleolar protein B23 in rat tissues and cells.","volume":"39","author":"Wang","year":"1993","journal-title":"Cell Mol Biol Res."},{"key":"2019111900465931200_B7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1110\/ps.8.4.905","article-title":"Nucleolar protein B23 has molecular chaperone activities.","volume":"8","author":"Szebeni","year":"1999","journal-title":"Protein Sci."},{"key":"2019111900465931200_B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0092-8674(00)00093-3","article-title":"Nucleophosmin\/B23 is a target of CDK2\/cyclin E in centrosome duplication.","volume":"103","author":"Okuda","year":"2000","journal-title":"Cell."},{"key":"2019111900465931200_B9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.onc.1200849","article-title":"Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.","volume":"14","author":"Iwahara","year":"1997","journal-title":"Oncogene."},{"key":"2019111900465931200_B10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.onc.1201062","article-title":"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK).","volume":"14","author":"Morris","year":"1997","journal-title":"Oncogene."},{"key":"2019111900465931200_B11","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1038\/sj.onc.1204594","article-title":"Translocations involving anaplastic lymphoma kinase (ALK).","volume":"20","author":"Duyster","year":"2001","journal-title":"Oncogene."},{"key":"2019111900465931200_B12","doi-asserted-by":"crossref","first-page":"9526","DOI":"10.1074\/jbc.M007333200","article-title":"Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway.","volume":"276","author":"Souttou","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111900465931200_B13","doi-asserted-by":"crossref","first-page":"16772","DOI":"10.1074\/jbc.M010660200","article-title":"Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.","volume":"276","author":"Stoica","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111900465931200_B14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod Pathol."},{"key":"2019111900465931200_B15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0002-9440(10)65042-0","article-title":"Expression of the ALK tyrosine kinase gene in neuroblastoma.","volume":"156","author":"Lamant","year":"2000","journal-title":"Am J Pathol."},{"key":"2019111900465931200_B16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation.","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood."},{"key":"2019111900465931200_B17","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1128\/MCB.18.12.6951","article-title":"Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity.","volume":"18","author":"Bai","year":"1998","journal-title":"Mol Cell Biol."},{"key":"2019111900465931200_B18","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/blood.V90.8.2901","article-title":"Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.","volume":"90","author":"Kuefer","year":"1997","journal-title":"Blood."},{"key":"2019111900465931200_B19","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","article-title":"Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.","volume":"17","author":"Bischof","year":"1997","journal-title":"Mol Cell Biol."},{"key":"2019111900465931200_B20","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood.V96.13.4319","article-title":"Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase\/Akt antiapoptotic signaling pathway.","volume":"96","author":"Bai","year":"2000","journal-title":"Blood."},{"key":"2019111900465931200_B21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma.","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol."},{"key":"2019111900465931200_B22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene."},{"key":"2019111900465931200_B23","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0002-9440(10)64690-1","article-title":"The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.","volume":"158","author":"Maes","year":"2001","journal-title":"Am J Pathol."},{"key":"2019111900465931200_B24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(94)90140-6","article-title":"A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.","volume":"77","author":"Sawada","year":"1994","journal-title":"Cell."},{"key":"2019111900465931200_B25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway.","volume":"163","author":"Chiarle","year":"1999","journal-title":"J Immunol."},{"key":"2019111900465931200_B26","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/MCB.22.23.8375-8387.2002","article-title":"In Vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.","volume":"22","author":"Piva","year":"2002","journal-title":"Mol Cell Biol."},{"key":"2019111900465931200_B27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood."},{"key":"2019111900465931200_B28","first-page":"1053","article-title":"Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.","volume":"13","author":"Mangues","year":"1996","journal-title":"Oncogene."},{"key":"2019111900465931200_B29","first-page":"2194","article-title":"Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin\/anaplastic lymphoma kinase-mediated lymphomagenesis.","volume":"61","author":"Slupianek","year":"2001","journal-title":"Cancer Res."},{"key":"2019111900465931200_B30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/10428199809068562","article-title":"The t(2;5) in human lymphomas.","volume":"29","author":"Kadin","year":"1998","journal-title":"Leuk Lymphoma."},{"key":"2019111900465931200_B31","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1073\/pnas.041475098","article-title":"Role of the F-box protein Skp2 in lymphomagenesis.","volume":"98","author":"Latres","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111900465931200_B32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1073\/pnas.89.1.232","article-title":"Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.","volume":"89","author":"Suematsu","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111900465931200_B33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature."},{"key":"2019111900465931200_B34","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V91.9.3323","article-title":"High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus.","volume":"91","author":"Romagnani","year":"1998","journal-title":"Blood."},{"key":"2019111900465931200_B35","first-page":"274","article-title":"Establishment of a CD4-positive plasmacytoma cell line (AMO1).","volume":"7","author":"Shimizu","year":"1993","journal-title":"Leukemia."},{"key":"2019111900465931200_B36","first-page":"7682","article-title":"A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma.","volume":"50","author":"Kubonishi","year":"1990","journal-title":"Cancer Res."},{"key":"2019111900465931200_B37","first-page":"302","article-title":"T-cell antigen-positive multiple myeloma.","volume":"3","author":"Spier","year":"1990","journal-title":"Mod Pathol."},{"key":"2019111900465931200_B38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/222994a0","article-title":"Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane).","volume":"222","author":"Anderson","year":"1969","journal-title":"Nature."},{"key":"2019111900465931200_B39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/carcin\/13.10.1681","article-title":"Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.","volume":"13","author":"Potter","year":"1992","journal-title":"Carcinogenesis."},{"key":"2019111900465931200_B40","first-page":"91","article-title":"Interleukin-6 in myeloma\/plasmacytoma.","volume":"34","author":"Suematsu","year":"1993","journal-title":"Int Rev Exp Pathol."},{"key":"2019111900465931200_B41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ijc.2910460516","article-title":"Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.","volume":"46","author":"Sugiyama","year":"1990","journal-title":"Int J Cancer."},{"key":"2019111900465931200_B42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity."},{"key":"2019111900465931200_B43","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene."},{"key":"2019111900465931200_B44","first-page":"127","article-title":"Multiple myeloma: new aspects of biology and treatment.","volume":"44","author":"Ozaki","year":"1998","journal-title":"J Med Invest."},{"key":"2019111900465931200_B45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10428199409051673","article-title":"N- and K-ras oncogenes in plasma cell dyscrasias.","volume":"15","author":"Corradini","year":"1994","journal-title":"Leuk Lymphoma."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1919\/1262011\/h80503001919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1919\/1262011\/h80503001919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T08:03:58Z","timestamp":1682409838000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/5\/1919\/106637\/NPMALK-transgenic-mice-spontaneously-develop-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-05-1343","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}